Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study locations were updated by adding Qiryat Krinitzi, Israel, 52621 and removing Tel Litwinsky, Israel, 52621; the page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.0%
    Check dated 2026-08-31T18:30:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier was added to the study's list of Other Study ID Numbers, linking the trial to U.S. NIH funding.
    Difference
    0.0%
    Check dated 2026-08-24T20:02:14.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added contact details for the study locator service, including an email address and phone number, to facilitate outreach and inquiries regarding the study.
    Difference
    0.0%
    Check dated 2026-08-17T16:08:00.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.4 to v3.6.5, signaling a newer page version. This is a metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-10T14:24:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page version rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-27T06:18:39.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown on the page, replacing v3.6.2, indicating an internal version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-07-05T11:01:19.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.